ATOSSA THERAPEUTICS, INC. (ATOS)

Form 4 sales, Form 144 notices and lockup dates

Sales chart range
Log in to watch ATOS
Latest sale
$33k
Nov 15 · Unusual
Form 4 sales
4
On record
Form 144 notices
0
Proposed sales
Next unlock
None
No lockup ahead

Lockups

No lockup on record.

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Timeline

  1. 1 Form 4 salePlan not stated
    Oct 1 2013

    Sold 7,265 shares at $5.66 ($41k)

    Chen Shu-Chih, Chief Scientific Officer

    Sold 0.2% of holdings ($24.2M position)4.3M shares leftFirst sale on recordFiling

  2. 2 Form 4 salePlan not stated
    Oct 1 same day

    Sold 7,265 shares at $5.66 ($41k)

    Quay Steven C, CEO

    Sold 0.2% of holdings ($24.2M position)4.3M shares leftFirst sale on recordFiling

  3. 3 Form 4 saleUnusual
    Jul 2 +2831 days

    Sold 107,497 shares at $5.58 ($600k)

    Weaver Gregory L, Director

    Sold 100% of holdings ($600k position)0 shares leftFirst sale on recordFiling

  4. 4 Form 4 saleUnusual
    Nov 15 +866 days

    Sold 50,000 shares at $0.65 ($33k)

    Weaver Gregory L, Former EVP, CFO, & Director

    No 10b5-1 planSold 99.9% of holdings ($33k position)55 shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales, notices and lockups (4)

Export watchlist as CSV
Lockups, Form 144 notices and Form 4 sales for ATOS
Source
Nov 15, 2023Weaver Gregory LFormer EVP, CFO, & DirectorForm 4 sale50,000$33k99.9%UnusualSEC
Jul 2, 2021Weaver Gregory LDirectorForm 4 sale107,497$600k100.0%UnusualSEC
Oct 1, 2013Quay Steven CCEOForm 4 sale7,265$41k0.2%Plan not statedSEC
Oct 1, 2013Chen Shu-ChihChief Scientific OfficerForm 4 sale7,265$41k0.2%Plan not statedSEC